Ultragenyx Pharma (RARE) PT Lowered to $80 From $88 at Wedbush
Tweet Send to a Friend
Wedbush lowered its price target on Ultragenyx Pharma (NASDAQ: RARE) to $80.00 (from $88.00) while maintaining a Outperform rating.Analyst Dr ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
